Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties

Experimental Hematology

Volumn 27, Issue 4, 1999, Pages 751-761

  Boyer, Aurélie ^a   Andreu, Georges ^b   Romet Lemonne, Jean Loup ^c   Fridman, Wolf Herman ^a   Teillaud, Jean Luc ^a  

^a INSTITUT CURIE   (France)

^b HÔTEL DIEU   (France)

^c Immuno Designed Molecules   (France)

Author keywords

Cell cytotoxicity; Dendritic cells; Fc R; Macrophages; Phagocytosis

Indexed keywords

DIHYDROXYCOLECALCIFEROL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; DENDRITIC CELL; DIAGNOSTIC VALUE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; MACROPHAGE FUNCTION; NORMAL HUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; CALCITRIOL; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-13; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; PHAGOCYTOSIS; SACCHAROMYCES CEREVISIAE;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0032929018     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00070-8     Document Type: Article

References (48)

1. Szabolcs P., Avigan D., Gezelter S., Ciocon D.H., Moore M.A., Steinman R.M., Young J.W. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 87:1996;4520.
2. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 9:1997;10.
3. Kelsey S.M., Makin H.L., Newland A.C. Functional significance of induction of differentiation in human myeloid leukaemic blasts by 1,25-dihydroxyvitamin D3 and GM-CSF. Leukemia Res. 16:1992;427.
4. Dodd R.C., Cohen M.S., Newman S.L., Gray T.K. Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proc Natl Acad Sci U S A. 80:1983;7538.
5. Kreutz M., Andreesen R. Induction of human monocyte to macrophage maturation in vitro by 1,25-dihydroxyvitamin D3. Blood. 76:1990;2457.
6. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109.
7. Thurnher M., Papesh C., Ramoner R., Gastl G., Bock G., Radmayr C., Klocker H., Bartsch G. In vitro generation of CD83(+) human blood dendritic cells for active tumor immunotherapy. Exp Hemat. 25:1997;232.
8. Piemonti L., Bernasconi S., Luini W., Trobonjaca Z., Minty A., Allavena P., Mantovani A. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur Cytokine Network. 6:1995;245.
9. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245.
10. Connor R.I., Shen L., Fanger M.W. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level. J Immunol. 145:1990;1483.
11. van Schie R.C., Verstraten R.G., van de Winkel J.G., Tax W.J., de Mulder P.H. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism. J Immunol. 148:1992;169.
12. Cannon G.J., Swanson J.A. The macrophage capacity for phagocytosis. J Cell Sci. 101:1992;907.
13. van de Winkel J.G. Human IgG Fc receptors. Mol Biol Intelligence Unit, Chapman & Hall. 4:1996;57.
14. Trinchieri G. Immune interferon. a pleiotropic lymphokine with multiple effects Immunol Today. 6:1985;131.
15. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 137:1973;1142.
16. Steinman R.M., Lustig D.S., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. III. Functional properties in vivo. J Exp Med. 139:1974;1431.
17. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med. 139:1974;380.
18. Steinman R.M., Adams J.C., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med. 141:1975;804.
19. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V.S., Davoust J., Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med. 185:1997;317.
20. Steinman R.M., Swanson J. The endocytic activity of dendritic cells. J Exp Med. 182:1995;283.
21. Backman K.A., Guyre P.M. Gamma-interferon inhibits Fc receptor II-mediated phagocytosis of tumor cells by human macrophages. Cancer Res. 54:1994;2456.
22. Munn D.H., Cheung N.K. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med. 172:1990;231.
23. Munn D.H., McBride M., Cheung N.K. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages. Cancer Res. 51:1991;1117.
24. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or lysate-pulsed dendritic cells. Nature Med. 4:1998;328.
25. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86.
26. Herve P. The emergence of cell therapy in France. Public health, regulation and other controversial issues. Hematol Cell Ther. 1997:1997;189.
27. Chokri M., Lopez M., Oleron C., Girard A., Martinache C., Canepa S., Siffert J.C., Bartholeyns J. Production of human macrophages with potent antitumor properties (MAK) by culture of monocytes in the presence of GM-CSF and 1,25-dihydroxy vitamin D3. Anticancer Res. 12:1992;2257.
28. Chokri M., Girard A., Borrelly M.C., Oleron C., Romet-Lemonne J.L., Bartholeyns J. Adoptive immunotherapy with bispecific antibodies. targeting through macrophages Res Immunol. 143:1992;95.
29. Vely F., Gruel N., Moncuit J., Cochet O., Rouard H., Dare S., Galon J., Sautes C., Fridman W.H., Teillaud J.L. A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16). characterization and use in various assays Hybridoma. 16:1997;519.
30. Giaimis J., Lombard Y., Fonteneau P., Muller C.D., Levy R., Makaya-Kumba M., Lazdins J., Poindron P. Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. J Leukocyte Biol. 54:1993;564.
31. Ely P., Wallace P.K., Givan A.L., Graziano R.F., Guyre P.M., Fanger M.W. Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood. 87:1996;3813.
32. Michon J., Moutel S., Barbet J., Romet-Lemonne J.L., Deo Y.M., Fridman W.H., Teillaud J.L. In vitro killing of neuroblastoma cells by neutrophils derived from granulocyte colony-stimulating factor-treated cancer patients using an anti-disialoganglioside/anti-Fc gamma RI bispecific antibody. Blood. 86:1995;1124.
33. Kawasaki N., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem. 94:1983;937.
34. Ofek I., Goldhar J., Keisari Y., Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol. 49:1995;239.
35. Tenner A.J., Robinson S.L., Ezekowitz R.A. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity. 3:1995;485.
36. Avrameas A., McIlroy D., Hosmalin A., Autran B., Debre P., Monsigny M., Roche A.C., Midoux P. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur J Immunol. 26:1996;394.
37. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment. downregulation by cytokines and bacterial products J Exp Med. 182:1995;389.
38. Dougherty G.J., Selvendran Y., Murdoch S., Palmer D.G., Hogg N. The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol. 17:1987;1453.
39. Minty A., Asselin S., Bensussan A., Shire D., Vita N., Vyakarnam A., Wijdenes J., Ferrara P., Caput D. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Network. 8:1997;203.
40. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:1993;248.
41. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A. 93:1996;2588.
42. Zhou L.J., Tedder T.F. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood. 86:1995;3295.
43. Rattis F.M., Peguet-Navarro J., Staquet M.J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol. 26:1996;449.
44. Fanger N.A., Wardwell K., Shen L., Tedder T.F., Guyre P.M. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol. 157:1996;541.
45. Shepherd V.L., Campbell E.J., Senior R.M., Stahl P.D. Characterization of the mannose/fucose receptor on human mononuclear phagocytes. J Reticuloendothelial Soc. 32:1982;423.
46. de Velde A.A., de Waal Malef ijt R., Huijbens R.J., de Vries J.E., Figdor C.G. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol. 149:1992;4048.
47. Hart D. Dendritic cells. unique leukocyte populations which control the primary immune response Blood. 90:1997;3245.
48. Girolomoni G., Ricciardi-Castagnoli P. Dendritic cells hold promise for immunotherapy. Immunol Today. 18:1997;102.